KennethCAndersonMDFCCP

Pulmonology • Louisville, KY

Critical Care Medicine, Sleep Medicine

Chief Medical Officer, Vice President, Baptist Hospital Louisville

Join to view full profile

Dr. Anderson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Anderson's full profile

Already have an account?

Office
4000 Kresge Way
Louisville, KY 40207
Phone+1 502-897-8101
Is this information wrong?

Education & Training

University of Louisville School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1991
University of Louisville School of MedicineResidency, Internal Medicine, 1986 - 1989
University of Louisville School of MedicineClass of 1986

Certifications & Licensure

KY State Medical License 1987 - 2025
IN State Medical License 1987 - 2025

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Publications & Presentations

Lectures

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Genome-Wide CRISPR-Cas9 Screening Reveals a Role for TRAF2 in Resistance to IMiDs in Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Chromatin Accessibility Profiling Reveals Cis-Regulatory Heterogeneity and Novel Transcription Factor Dependencies in Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Inhibitor of DNA Binding 2 (ID2) Plays a Key Tumor Suppressor Role in Promoting Oncogenic Transformation in Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Plasmacytoid Dendritic Cells Trigger Contact-Dependent Tumor Promoting Genetic Alterations in Multiple Myeloma Cells
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
The Critical Role of HDAC1-IRF4-Pim-2 Axis in Myeloma Cell Growth and Survival: Therapeutic Impacts of Targeting the HDAC1-IRF4-Pim-2 Axis
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Optimizing Mechanisms for Induction of Immunogenic Cell Death to Improve Patient Outcome in Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Targeting Tryptophan Catabolic Kynurenine Pathway Enhances Anti-Tumor Immunity and Cytotoxicity in Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Landscape of Recurrent Mutations in Non-Coding Genome with Functional Implications in Newly-Diagnosed Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
The Landscape of Structural Variant Signatures in Multiple Myeloma Identifies Distinct Disease Subgroups with Implications for Pathogenesis
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Join now to see all